Integrated prospective results from the deflazacort clinical program suggest less severe psychiatric adverse events with deflazacort versus prednisone in Duchenne muscular dystrophy

Saved in:
Bibliographic Details
Published in:Neuromuscular disorders : NMD 2016-10, Vol.26, p.S180-S180
Main Authors: Dubow, J, Sazani, P, Cunniff, T, Wanaski, S, Meyer, J
Format: Article
Language:English
Subjects:
Neurology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0960-8966
DOI:10.1016/j.nmd.2016.06.340